Weight-loss medications, including Zepbound and Wegovy, are being compared in terms of their differences and effectiveness. These medications, which include GLP-1 drugs such as tirzepatide and semaglutide, are being evaluated for their ability to aid in weight loss, as well as their potential side effects and safety. The medications are part of a broader class of weight-loss treatments that also includes other options, such as retatrutide, which has shown significant weight-loss results.